FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2160609898> ?p ?o ?g. }

• W2160609898 abstract "Reducing low-density lipoprotein cholesterol (LDL-C) is associated with reduced risk for major coronary events. Despite statin efficacy, a considerable proportion of statin-treated hypercholesterolemic patients fail to reach therapeutic LDL-C targets as defined by guidelines. This study compared the efficacy of ezetimibe added to ongoing statins with doubling the dose of ongoing statin in a population of Taiwanese patients with hypercholesterolemia.This was a randomized, open-label, parallel-group comparison study of ezetimibe 10 mg added to ongoing statin compared with doubling the dose of ongoing statin. Adult Taiwanese hypercholesterolemic patients not at optimal LDL-C levels with previous statin treatment were randomized (N = 83) to ongoing statin + ezetimibe (simvastatin, atorvastatin or pravastatin + ezetimibe at doses of 20/10, 10/10 or 20/10 mg) or doubling the dose of ongoing statin (simvastatin 40 mg, atorvastatin 20 mg or pravastatin 40 mg) for 8 weeks. Percent change in total cholesterol, LDL-C, high-density lipoprotein cholesterol (HDL-C) and triglycerides, and specified safety parameters were assessed at 4 and 8 weeks.At 8 weeks, patients treated with statin + ezetimibe experienced significantly greater reductions compared with doubling the statin dose in LDL-C (26.2% vs 17.9%, p = 0.0026) and total cholesterol (20.8% vs 12.2%, p = 0.0003). Percentage of patients achieving treatment goal was greater for statin + ezetimibe (58.6%) vs doubling statin (41.2%), but the difference was not statistically significant (p = 0.1675). The safety and tolerability profiles were similar between treatments.Ezetimibe added to ongoing statin therapy resulted in significantly greater lipid-lowering compared with doubling the dose of statin in Taiwanese patients with hypercholesterolemia. Studies to assess clinical outcome benefit are ongoing.Registered at ClinicalTrials.gov: NCT00652327." @default.
• W2160609898 created "2016-06-24" @default.
• W2160609898 creator A5004312762 @default.
• W2160609898 creator A5011776667 @default.
• W2160609898 creator A5024523357 @default.
• W2160609898 creator A5034479330 @default.
• W2160609898 creator A5044922945 @default.
• W2160609898 creator A5057929659 @default.
• W2160609898 creator A5077955682 @default.
• W2160609898 creator A5082752193 @default.
• W2160609898 date "2012-05-23" @default.
• W2160609898 modified "2023-10-16" @default.
• W2160609898 title "Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trial" @default.
• W2160609898 cites W1974322580 @default.
• W2160609898 cites W2001375687 @default.
• W2160609898 cites W2008333077 @default.
• W2160609898 cites W2012863782 @default.
• W2160609898 cites W2016253197 @default.
• W2160609898 cites W2020158846 @default.
• W2160609898 cites W2020632420 @default.
• W2160609898 cites W2022128185 @default.
• W2160609898 cites W2025041596 @default.
• W2160609898 cites W2028693103 @default.
• W2160609898 cites W2029158612 @default.
• W2160609898 cites W2033048555 @default.
• W2160609898 cites W2034336678 @default.
• W2160609898 cites W2076289046 @default.
• W2160609898 cites W2104982711 @default.
• W2160609898 cites W2113284407 @default.
• W2160609898 cites W2117216433 @default.
• W2160609898 cites W2123341306 @default.
• W2160609898 cites W2129750583 @default.
• W2160609898 cites W2132931461 @default.
• W2160609898 cites W2144790234 @default.
• W2160609898 cites W2155598961 @default.
• W2160609898 cites W2159449551 @default.
• W2160609898 cites W2163252871 @default.
• W2160609898 cites W2163424622 @default.
• W2160609898 cites W2164232957 @default.
• W2160609898 cites W2164551379 @default.
• W2160609898 cites W2167067204 @default.
• W2160609898 cites W2169523655 @default.
• W2160609898 cites W2170452015 @default.
• W2160609898 cites W2171943141 @default.
• W2160609898 cites W2305718992 @default.
• W2160609898 cites W2322095705 @default.
• W2160609898 cites W4238251256 @default.
• W2160609898 doi "https://doi.org/10.1186/1756-0500-5-251" @default.
• W2160609898 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3403927" @default.
• W2160609898 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22621316" @default.
• W2160609898 hasPublicationYear "2012" @default.
• W2160609898 type Work @default.
• W2160609898 sameAs 2160609898 @default.
• W2160609898 citedByCount "10" @default.
• W2160609898 countsByYear W21606098982014 @default.
• W2160609898 countsByYear W21606098982017 @default.
• W2160609898 countsByYear W21606098982018 @default.
• W2160609898 countsByYear W21606098982019 @default.
• W2160609898 countsByYear W21606098982020 @default.
• W2160609898 countsByYear W21606098982021 @default.
• W2160609898 crossrefType "journal-article" @default.
• W2160609898 hasAuthorship W2160609898A5004312762 @default.
• W2160609898 hasAuthorship W2160609898A5011776667 @default.
• W2160609898 hasAuthorship W2160609898A5024523357 @default.
• W2160609898 hasAuthorship W2160609898A5034479330 @default.
• W2160609898 hasAuthorship W2160609898A5044922945 @default.
• W2160609898 hasAuthorship W2160609898A5057929659 @default.
• W2160609898 hasAuthorship W2160609898A5077955682 @default.
• W2160609898 hasAuthorship W2160609898A5082752193 @default.
• W2160609898 hasBestOaLocation W21606098981 @default.
• W2160609898 hasConcept C126322002 @default.
• W2160609898 hasConcept C168563851 @default.
• W2160609898 hasConcept C197934379 @default.
• W2160609898 hasConcept C2776329913 @default.
• W2160609898 hasConcept C2776839432 @default.
• W2160609898 hasConcept C2777482532 @default.
• W2160609898 hasConcept C2778163477 @default.
• W2160609898 hasConcept C2778375690 @default.
• W2160609898 hasConcept C2778657065 @default.
• W2160609898 hasConcept C2779519902 @default.
• W2160609898 hasConcept C2908647359 @default.
• W2160609898 hasConcept C71924100 @default.
• W2160609898 hasConcept C90924648 @default.
• W2160609898 hasConcept C98274493 @default.
• W2160609898 hasConcept C99454951 @default.
• W2160609898 hasConceptScore W2160609898C126322002 @default.
• W2160609898 hasConceptScore W2160609898C168563851 @default.
• W2160609898 hasConceptScore W2160609898C197934379 @default.
• W2160609898 hasConceptScore W2160609898C2776329913 @default.
• W2160609898 hasConceptScore W2160609898C2776839432 @default.
• W2160609898 hasConceptScore W2160609898C2777482532 @default.
• W2160609898 hasConceptScore W2160609898C2778163477 @default.
• W2160609898 hasConceptScore W2160609898C2778375690 @default.
• W2160609898 hasConceptScore W2160609898C2778657065 @default.
• W2160609898 hasConceptScore W2160609898C2779519902 @default.
• W2160609898 hasConceptScore W2160609898C2908647359 @default.
• W2160609898 hasConceptScore W2160609898C71924100 @default.
• W2160609898 hasConceptScore W2160609898C90924648 @default.
• W2160609898 hasConceptScore W2160609898C98274493 @default.
• W2160609898 hasConceptScore W2160609898C99454951 @default.

• next